IMAX (IMAX) Financials

$33.84 -0.38 (-1.12%)

Closing price 03:59 PM Eastern

Extended Trading

$36.12 +2.28 (+6.74%)

As of 07:45 PM Eastern

Annual Income Statements for IMAX

This table shows IMAX's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Income / (Loss) Attributable to Common Shareholders	56	29	2.34	23	47	-144	-22	-23	25	26	35
Consolidated Net Income / (Loss)	65	39	13	34	59	-157	-9.58	-20	33	33	46
Net Income / (Loss) Continuing Operations	65	39	13	34	59	-157	-9.58	-20	33	33	46
Total Pre-Tax Income	87	58	30	44	75	-129	11	-9.77	46	38	63
Total Operating Income	88	59	31	45	77	-122	11	-4.83	50	44	84
Total Gross Profit	219	203	185	205	212	2.33	134	156	214	190	246
Total Revenue	374	377	381	374	396	137	255	301	375	352	410
Operating Revenue	374	377	381	374	396	137	255	301	375	352	410
Total Cost of Revenue	155	175	196	170	184	135	117	144	160	162	164
Operating Cost of Revenue	155	175	196	166	181	116	120	144	160	162	164
Total Operating Expenses	132	144	154	160	134	125	127	161	164	146	162
Selling, General & Admin Expense	115	124	110	117	123	108	117	138	144	133	138
Research & Development Expense	13	16	21	14	5.20	5.62	6.94	5.30	10	5.10	5.82
Amortization Expense	1.86	2.08	3.02	4.15	4.96	5.39	4.88	4.83	4.58	5.76	7.52
Other Operating Expenses / (Income)	0.75	0.95	2.65	2.99	-	-	-	8.55	1.76	-0.97	0.70
Impairment Charge	0.83	0.42	1.23	0.00	0.00	1.15	0.00	4.47	0.14	0.00	7.00
Restructuring Charge	0.00	0.00	16	9.54	0.85	0.00	0.00	0.00	2.95	3.75	2.48
Total Other Income / (Expense), net	-0.69	-0.74	-1.43	-1.57	-1.94	-6.70	0.00	-4.94	-4.28	-6.16	-21
Interest Expense	1.66	2.23	1.94	2.92	3.53	7.01	7.09	6.43	7.23	8.47	23
Interest & Investment Income	-	-	1.03	1.84	1.59	0.31	7.56	1.50	2.95	2.31	1.93
Income Tax Expense	20	16	17	9.52	17	27	21	10	13	5.00	18
Net Income / (Loss) Attributable to Noncontrolling Interest	8.78	11	10	11	12	-14	13	2.92	7.73	6.64	11
Basic Earnings per Share	$0.79	$0.43	$0.04	$0.36	$0.76	($2.43)	($0.38)	($0.40)	$0.47	$0.49	$0.65
Weighted Average Basic Shares Outstanding	70.70M	66.90M	58.60M	61.48M	61.36M	59.24M	59.13M	56.67M	54.31M	52.65M	53.64M
Diluted Earnings per Share	$0.78	$0.42	$0.04	$0.36	$0.76	($2.43)	($0.38)	($0.40)	$0.46	$0.48	$0.63
Weighted Average Diluted Shares Outstanding	70.70M	66.90M	58.60M	61.48M	61.36M	59.24M	59.13M	56.67M	55.15M	53.86M	55.54M
Weighted Average Basic & Diluted Shares Outstanding	70.70M	66.90M	58.60M	61.48M	61.36M	58.95M	58.58M	53.97M	52.95M	53.02M	53.99M

This table shows IMAX's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
Net Income / (Loss) Attributable to Common Shareholders	12	2.54	3.27	3.58	14	5.31	2.33	11	21	0.64	4.23
Consolidated Net Income / (Loss)	15	3.31	5.42	5.07	15	6.87	8.15	12	23	2.53	6.07
Net Income / (Loss) Continuing Operations	15	3.31	5.42	5.07	15	6.87	8.15	12	23	2.53	6.07
Total Pre-Tax Income	22	1.46	11	1.08	18	8.32	15	13	28	6.60	8.49
Total Operating Income	22	2.74	12	2.87	19	9.51	17	14	29	24	9.95
Total Gross Profit	63	44	47	44	51	48	53	54	67	72	46
Total Revenue	104	86	79	89	91	93	87	92	107	125	81
Operating Revenue	104	86	79	89	91	93	87	92	107	125	81
Total Cost of Revenue	41	42	32	45	40	44	33	38	39	53	36
Operating Cost of Revenue	41	42	32	45	40	44	33	38	39	53	36
Total Operating Expenses	41	41	35	41	32	39	36	39	38	48	36
Selling, General & Admin Expense	36	35	31	38	31	32	33	35	34	35	32
Research & Development Expense	2.77	2.72	2.19	2.03	-0.27	1.15	1.32	1.54	1.51	1.45	1.80
Amortization Expense	1.11	1.25	1.34	1.32	1.54	1.55	1.73	1.81	1.91	2.07	2.03
Other Operating Expenses / (Income)	0.52	-	-	0.14	-1.14	-	-0.13	-0.18	0.60	-	-0.46
Restructuring Charge	0.00	1.59	0.00	0.00	0.00	3.75	0.06	0.79	0.00	1.64	0.00
Total Other Income / (Expense), net	-0.46	-1.28	-1.49	-1.80	-1.69	-1.19	-1.30	-0.91	-1.22	-18	-1.46
Interest Expense	1.56	2.03	1.95	2.39	2.35	1.90	1.80	2.06	1.82	17	1.90
Interest & Investment Income	1.10	0.68	0.56	0.59	0.66	0.49	0.57	1.15	0.59	-0.38	0.50
Other Income / (Expense), net	-	-	-0.11	-	-	-	-0.07	-	-	-	-0.07
Income Tax Expense	6.56	-1.85	5.16	-4.00	2.38	1.46	7.29	1.20	5.21	4.08	2.42
Net Income / (Loss) Attributable to Noncontrolling Interest	3.03	0.77	2.15	1.49	1.45	1.56	5.82	0.98	1.96	1.89	1.85
Basic Earnings per Share	$0.22	$0.05	$0.06	$0.07	$0.26	$0.10	$0.04	$0.21	$0.38	$0.02	$0.08
Weighted Average Basic Shares Outstanding	54.62M	54.31M	52.50M	52.63M	52.68M	52.65M	53.15M	53.75M	53.79M	53.64M	54.13M
Diluted Earnings per Share	$0.22	$0.05	$0.06	$0.07	$0.26	$0.09	$0.04	$0.20	$0.37	$0.02	$0.07
Weighted Average Diluted Shares Outstanding	55.54M	55.15M	53.41M	53.43M	54.09M	53.86M	54.97M	55.16M	55.57M	55.54M	56.39M
Weighted Average Basic & Diluted Shares Outstanding	54.61M	52.95M	52.62M	52.68M	52.68M	53.02M	53.74M	53.78M	53.80M	53.99M	54.86M

This table details how cash moves in and out of IMAX's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Change in Cash & Equivalents	211	-113	-46	-17	-32	208	-128	-92	-21	24	51
Net Cash From Operating Activities	84	78	85	110	90	-23	6.07	17	59	71	127
Net Cash From Continuing Operating Activities	114	122	85	110	90	-23	6.07	17	59	71	127
Net Income / (Loss) Continuing Operations	65	39	13	34	59	-157	-9.58	-20	33	33	46
Consolidated Net Income / (Loss)	65	39	13	34	59	-157	-9.58	-20	33	33	46
Depreciation Expense	43	46	67	57	63	53	56	57	60	66	62
Amortization Expense	-	-	-	-	0.51	0.90	2.51	3.18	2.24	1.97	1.98
Non-Cash Adjustments To Reconcile Net Income	31	41	54	23	33	61	19	44	27	23	53
Changes in Operating Assets and Liabilities, net	-54	-49	-48	-3.65	-65	20	-62	-67	-64	-53	-36
Net Cash From Investing Activities	-79	-65	-74	-57	-66	-9.26	-0.01	-53	-32	-41	-42
Net Cash From Continuing Investing Activities	-79	-65	-74	-57	-66	-9.26	-0.01	-53	-32	-41	-42
Purchase of Property, Plant & Equipment	-43	-15	-24	-13	-7.42	-0.70	-3.59	-8.42	-6.49	-8.43	-8.17
Acquisitions	-7.07	-6.70	-5.21	-8.70	-2.93	-1.90	-4.09	-20	-8.34	-8.45	-5.32
Sale and/or Maturity of Investments	-	-	-	-	-15	0.00	18	0.00	1.05	0.00	0.00
Other Investing Activities, net	-28	-43	-43	-35	-40	-6.65	-10	-25	-18	-24	-28
Net Cash From Financing Activities	205	-126	-58	-71	-57	241	-133	-59	-49	-6.04	-34
Net Cash From Continuing Financing Activities	205	-126	-58	-71	-57	241	-133	-59	-49	-6.04	-34
Repayment of Debt	-12	-20	-2.00	-53	-55	-1.07	-309	-5.88	-53	-43	-112
Repurchase of Preferred Equity	-	-117	-5.13	-0.92	-14	-3.09	-	-	-	-	-275
Repurchase of Common Equity	-51	-2.00	-46	-71	-22	-38	-24	-83	-27	-18	-1.45
Payment of Dividends	-9.51	0.00	0.00	-6.93	-4.38	-4.21	-4.89	-2.70	-1.44	0.00	0.00
Issuance of Debt	25	0.00	0.00	65	35	288	227	38	40	55	352
Other Financing Activities, net	33	10	-4.26	-12	1.81	-0.51	-22	-4.64	-6.95	-0.20	3.09

This table details how cash moves in and out of IMAX's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
Net Change in Cash & Equivalents	14	-33	4.82	11	13	-3.91	-3.52	12	34	8.06	-5.17
Net Cash From Operating Activities	29	4.01	-11	35	35	11	6.95	23	68	29	4.03
Net Cash From Continuing Operating Activities	29	4.01	-11	35	35	11	6.95	23	68	29	4.03
Net Income / (Loss) Continuing Operations	15	3.31	5.42	5.07	15	6.87	8.15	12	23	2.53	6.07
Consolidated Net Income / (Loss)	15	3.31	5.42	5.07	15	6.87	8.15	12	23	2.53	6.07
Depreciation Expense	19	14	15	19	15	17	15	16	16	16	15
Amortization Expense	0.49	0.49	0.49	0.49	0.49	0.49	0.49	0.49	0.51	0.49	0.53
Non-Cash Adjustments To Reconcile Net Income	5.73	7.29	4.93	9.39	4.40	4.60	4.57	7.56	7.21	32	-3.24
Changes in Operating Assets and Liabilities, net	-12	-21	-37	1.25	0.15	-17	-21	-13	22	-22	-15
Net Cash From Investing Activities	-10	-13	-7.14	-8.50	-15	-11	-15	-7.42	-13	-7.14	-6.93
Net Cash From Continuing Investing Activities	-10	-13	-7.14	-8.50	-15	-11	-15	-7.42	-13	-7.14	-6.93
Purchase of Property, Plant & Equipment	-1.53	-3.95	-1.10	-1.59	-1.13	-4.61	-1.65	-2.36	-2.74	-1.42	-2.13
Acquisitions	-1.94	-2.93	-1.59	-1.60	-1.61	-3.65	-1.23	-2.14	-0.54	-1.41	-0.79
Other Investing Activities, net	-6.67	-7.30	-4.44	-5.32	-12	-2.61	-12	-2.92	-9.45	-4.31	-4.00
Net Cash From Financing Activities	-4.59	-24	23	-16	-7.56	-5.09	4.23	-3.75	-21	-14	-2.76
Net Cash From Continuing Financing Activities	-4.59	-24	23	-16	-7.56	-5.09	4.23	-3.75	-21	-14	-2.76
Repayment of Debt	-4.17	-10	-0.16	-21	-11	-10	-10	-8.16	-77	-17	-20
Issuance of Debt	0.32	8.69	45	6.00	4.00	-	23	6.00	56	267	31
Other Financing Activities, net	-0.48	-0.01	-4.19	-0.78	-0.38	5.16	-8.56	-0.14	0.35	11	-14
Effect of Exchange Rate Changes	-	-	0.13	-	-0.06	-	-0.08	-	-	-	0.49

This table presents IMAX's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Total Assets	931	857	867	874	889	998	883	821	815	830	894
Total Current Assets	578	472	457	290	390	555	480	407	256	254	307
Cash & Equivalents	317	205	159	142	109	317	190	97	76	101	151
Accounts Receivable	215	218	260	93	100	56	110	136	136	108	108
Inventories, net	39	42	31	45	43	40	27	32	32	33	33
Prepaid Expenses	6.50	6.63	7.55	10	10	10	12	12	12	13	15
Plant, Property, & Equipment, net	218	245	277	281	307	277	260	253	243	240	243
Total Noncurrent Assets	134	140	133	303	192	165	143	161	315	336	344
Noncurrent Note & Lease Receivables	-	-	-	127	40	41	44	44	191	202	213
Goodwill	39	39	39	39	39	39	39	53	53	53	46
Intangible Assets	29	30	31	34	30	26	23	33	35	35	32
Noncurrent Deferred & Refundable Income Taxes	26	21	31	31	24	18	14	9.90	7.99	14	13
Other Noncurrent Operating Assets	41	50	32	70	43	27	22	21	28	31	40
Total Liabilities & Shareholders' Equity	931	857	867	874	889	998	883	821	815	830	894
Total Liabilities	253	231	263	274	246	533	453	491	469	452	466
Total Current Liabilities	224	203	238	130	133	208	128	143	137	121	125
Accounts Payable	23	20	24	32	20	21	16	25	26	20	19
Accrued Expenses	96	93	100	98	113	99	112	117	111	101	105
Total Noncurrent Liabilities	29	27	25	144	113	325	325	349	332	331	342
Long-Term Debt	29	27	25	38	18	306	226	263	252	266	279
Noncurrent Deferred Revenue	-	-	-	107	95	-	81	71	67	53	50
Noncurrent Deferred & Payable Income Tax Liabilities	-	-	-	-	0.00	19	18	15	13	13	13
Other Noncurrent Operating Liabilities	-	-	-	-	-	-	-	-	0.00	0.00	0.00
Redeemable Noncontrolling Interest	3.31	4.98	1.35	6.44	5.91	0.76	0.76	0.72	0.66	0.68	0.67
Total Equity & Noncontrolling Interests	674	622	602	593	637	464	430	329	345	378	427
Total Preferred & Common Equity	624	562	528	512	548	394	356	263	273	299	338
Total Common Equity	624	562	528	512	548	394	356	263	273	299	338
Common Stock	611	617	621	602	595	596	585	562	574	587	584
Retained Earnings	20	-47	-88	-85	-40	-203	-235	-293	-293	-275	-240
Accumulated Other Comprehensive Income / (Loss)	-7.44	-5.20	-0.63	-3.59	-3.19	0.99	2.53	-9.85	-12	-17	-10
Other Equity Adjustments	-	-	-	-	-	0.00	3.93	3.93	3.93	4.05	4.22
Noncontrolling Interest	50	60	75	81	89	70	74	66	72	78	89

This table presents IMAX's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025	Q2 2025	Q3 2025	Q1 2026
Period end date	9/30/2022	3/31/2023	6/30/2023	9/30/2023	3/31/2024	6/30/2024	9/30/2024	3/31/2025	6/30/2025	9/30/2025	3/31/2026
Total Assets	800	822	816	851	824	827	848	848	869	890	893
Total Current Assets	385	406	396	429	396	263	270	265	286	308	307
Cash & Equivalents	87	99	95	110	81	92	105	97	109	143	146
Accounts Receivable	126	123	126	136	141	122	114	122	127	108	109
Inventories, net	36	37	37	45	36	38	38	32	37	41	36
Prepaid Expenses	13	14	12	13	13	12	13	14	13	15	17
Plant, Property, & Equipment, net	252	248	239	238	240	238	245	245	244	244	241
Total Noncurrent Assets	164	168	181	184	188	327	333	338	339	338	345
Noncurrent Note & Lease Receivables	44	47	57	59	65	193	198	203	204	203	212
Goodwill	62	53	53	53	53	53	53	53	53	53	46
Intangible Assets	22	33	34	34	35	35	34	35	34	33	31
Noncurrent Deferred & Refundable Income Taxes	14	11	11	12	7.71	16	16	14	14	13	13
Other Noncurrent Operating Assets	21	22	24	25	28	30	32	33	34	36	44
Total Liabilities & Shareholders' Equity	800	822	816	851	824	827	848	848	869	890	893
Total Liabilities	462	488	478	494	491	484	480	464	464	453	465
Total Current Liabilities	142	213	141	228	120	189	191	118	117	183	161
Accounts Payable	23	26	24	38	19	20	26	25	32	22	17
Accrued Expenses	119	114	117	124	101	106	111	93	85	96	88
Current Deferred Revenue	-	74	-	66	-	63	54	-	-	65	56
Total Noncurrent Liabilities	321	275	337	266	371	295	289	346	346	270	303
Long-Term Debt	229	259	256	252	297	283	276	280	278	257	291
Noncurrent Deferred & Payable Income Tax Liabilities	15	16	14	13	13	13	13	13	13	13	13
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	0.00	0.00
Redeemable Noncontrolling Interest	0.74	0.73	0.73	0.66	0.65	0.66	0.67	0.68	0.69	0.72	0.69
Total Equity & Noncontrolling Interests	337	333	337	357	333	342	367	384	404	436	428
Total Preferred & Common Equity	273	264	271	287	259	267	289	300	320	350	335
Total Common Equity	273	264	271	287	259	267	289	300	320	350	335
Common Stock	569	560	566	570	565	571	577	584	591	598	576
Retained Earnings	-283	-292	-284	-272	-297	-294	-280	-272	-261	-241	-236
Accumulated Other Comprehensive Income / (Loss)	-16	-7.88	-15	-15	-13	-14	-11	-16	-14	-12	-8.66
Other Equity Adjustments	3.93	3.93	3.93	3.93	3.93	3.93	3.93	4.11	4.22	4.22	4.22
Noncontrolling Interest	64	69	66	70	74	75	78	84	84	86	92

This table displays calculated financial ratios and metrics derived from IMAX's official financial filings.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	28.66%	0.94%	0.91%	-1.67%	5.68%	-65.37%	86.04%	18.02%	24.61%	-6.04%	16.47%
EBITDA Growth	42.93%	-18.98%	-8.29%	4.48%	37.85%	-148.46%	201.32%	-20.42%	104.81%	-1.17%	33.53%
EBIT Growth	52.28%	-32.29%	-48.53%	44.46%	72.97%	-257.64%	108.64%	-145.95%	1,142.57%	-12.97%	92.03%
NOPAT Growth	56.12%	-37.57%	-67.16%	154.94%	70.12%	-241.94%	88.77%	64.66%	1,167.90%	5.30%	59.23%
Net Income Growth	53.25%	-39.16%	-68.16%	168.37%	74.34%	-368.88%	93.92%	-107.55%	266.35%	-1.10%	39.21%
EPS Growth	39.29%	-46.15%	-90.48%	800.00%	111.11%	-419.74%	84.36%	-5.26%	215.00%	4.35%	31.25%
Operating Cash Flow Growth	-3.11%	-7.52%	9.62%	28.82%	-17.82%	-125.46%	126.36%	185.59%	238.40%	20.85%	79.38%
Free Cash Flow Firm Growth	-58.79%	-617.39%	59.45%	251.94%	66.57%	-37.85%	-412.95%	10.55%	128.22%	72.59%	215.69%
Invested Capital Growth	19.73%	15.46%	4.71%	5.16%	8.42%	-18.04%	5.98%	6.16%	5.48%	4.30%	2.08%
Revenue Q/Q Growth	4.73%	-3.19%	5.15%	-4.24%	4.03%	-33.26%	25.99%	-3.38%	-3.11%	1.93%	8.61%
EBITDA Q/Q Growth	4.93%	-12.39%	24.59%	-24.17%	23.62%	-180.35%	171.16%	-26.33%	-4.63%	9.68%	10.42%
EBIT Q/Q Growth	5.20%	-20.78%	17.27%	-31.94%	46.03%	-47.65%	136.10%	-136.45%	-8.69%	18.26%	20.95%
NOPAT Q/Q Growth	7.04%	-26.04%	-20.73%	-28.70%	76.33%	-47.65%	53.07%	79.11%	-1.80%	8.53%	13.43%
Net Income Q/Q Growth	6.13%	-26.49%	-21.25%	-12.79%	42.89%	-35.08%	77.47%	-87.89%	-2.28%	12.20%	-8.71%
EPS Q/Q Growth	4.00%	-31.15%	-55.56%	-12.20%	52.00%	-37.29%	58.70%	-48.15%	2.22%	9.09%	-10.00%
Operating Cash Flow Q/Q Growth	47.58%	-10.99%	-11.07%	22.17%	-17.21%	-198.88%	151.51%	-33.71%	-17.96%	11.80%	16.39%
Free Cash Flow Firm Q/Q Growth	108.28%	-190.69%	-21.43%	160.36%	297.25%	23.67%	-209.14%	10.85%	-41.68%	459.80%	16.94%
Invested Capital Q/Q Growth	-2.64%	2.83%	2.18%	-2.18%	0.23%	-6.09%	1.43%	3.23%	4.26%	0.80%	0.79%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	58.66%	53.71%	48.65%	54.70%	53.52%	1.70%	52.73%	51.98%	57.18%	54.00%	60.02%
EBITDA Margin	35.19%	28.24%	25.67%	27.27%	35.58%	-49.79%	27.12%	18.29%	30.05%	31.61%	36.24%
Operating Margin	23.48%	15.53%	8.26%	12.07%	19.53%	-88.92%	4.31%	-1.61%	13.45%	12.45%	20.53%
EBIT Margin	23.74%	15.92%	8.12%	11.93%	19.53%	-88.92%	4.13%	-1.61%	13.45%	12.45%	20.53%
Profit (Net Income) Margin	17.29%	10.42%	3.29%	8.97%	14.80%	-114.95%	-3.76%	-6.61%	8.82%	9.28%	11.10%
Tax Burden Percent	74.21%	67.97%	41.71%	77.04%	77.75%	121.96%	-87.17%	203.47%	71.70%	86.75%	71.93%
Interest Burden Percent	98.13%	96.28%	97.04%	97.60%	97.49%	105.99%	104.43%	202.09%	91.51%	85.95%	75.14%
Effective Tax Rate	23.03%	28.02%	55.95%	21.83%	22.26%	0.00%	187.17%	0.00%	28.30%	13.25%	28.07%
Return on Invested Capital (ROIC)	18.93%	10.06%	3.01%	7.32%	11.66%	-17.48%	-2.12%	-0.70%	7.11%	7.14%	11.02%
ROIC Less NNEP Spread (ROIC-NNEP)	20.43%	11.29%	3.87%	8.77%	13.08%	91.70%	-2.17%	-17.21%	5.31%	4.01%	0.75%
Return on Net Nonoperating Assets (RNNOA)	-7.22%	-4.03%	-0.98%	-1.74%	-2.23%	-10.95%	-0.02%	-4.52%	2.68%	1.89%	0.27%
Return on Equity (ROE)	11.71%	6.03%	2.04%	5.59%	9.43%	-28.43%	-2.14%	-5.23%	9.79%	9.04%	11.30%
Cash Return on Invested Capital (CROIC)	0.97%	-4.28%	-1.58%	2.29%	3.57%	2.35%	-7.92%	-6.68%	1.78%	2.93%	8.97%
Operating Return on Assets (OROA)	11.43%	6.72%	3.59%	5.13%	8.77%	-12.91%	1.12%	-0.57%	6.16%	5.33%	9.77%
Return on Assets (ROA)	8.33%	4.40%	1.45%	3.86%	6.65%	-16.69%	-1.02%	-2.33%	4.04%	3.98%	5.28%
Return on Common Equity (ROCE)	10.68%	5.49%	1.80%	4.83%	8.04%	-24.17%	-1.79%	-4.26%	7.78%	7.15%	8.93%
Return on Equity Simple (ROE_SIMPLE)	10.36%	7.00%	2.37%	6.56%	10.69%	-39.97%	-2.69%	-7.55%	12.11%	10.92%	0.00%
Net Operating Profit after Tax (NOPAT)	68	42	14	35	60	-85	-9.57	-3.38	36	38	61
NOPAT Margin	18.07%	11.18%	3.64%	9.43%	15.18%	-62.24%	-3.76%	-1.12%	9.64%	10.80%	14.77%
Net Nonoperating Expense Percent (NNEP)	-1.51%	-1.23%	-0.86%	-1.44%	-1.42%	-109.18%	0.05%	16.50%	1.80%	3.13%	10.28%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	-0.57%	6.05%	5.91%	8.59%
Cost of Revenue to Revenue	41.34%	46.29%	51.35%	45.30%	46.48%	98.30%	45.72%	48.02%	42.82%	46.00%	39.98%
SG&A Expenses to Revenue	30.86%	32.95%	28.86%	31.38%	31.20%	79.18%	46.03%	45.89%	38.52%	37.68%	33.75%
R&D to Revenue	3.41%	4.32%	5.48%	3.67%	1.32%	4.10%	2.72%	1.76%	2.70%	1.45%	1.42%
Operating Expenses to Revenue	35.18%	38.18%	40.39%	42.63%	33.98%	91.06%	49.97%	53.59%	43.74%	41.55%	39.48%
Earnings before Interest and Taxes (EBIT)	89	60	31	45	77	-122	11	-4.83	50	44	84
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	132	107	98	102	141	-68	69	55	113	111	149
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	3.94	3.73	2.84	2.30	2.29	2.69	2.96	3.12	3.00	4.50	5.88
Price to Tangible Book Value (P/TBV)	4.42	4.26	3.28	2.68	2.62	3.23	3.59	4.62	4.43	6.38	7.66
Price to Revenue (P/Rev)	6.58	5.56	3.94	3.14	3.16	7.74	4.14	2.73	2.19	3.83	4.85
Price to Earnings (P/E)	44.04	72.88	639.54	51.53	26.72	0.00	0.00	0.00	32.37	51.75	57.01
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	2.27%	1.37%	0.16%	1.94%	3.74%	0.00%	0.00%	0.00%	3.09%	1.93%	1.75%
Enterprise Value to Invested Capital (EV/IC)	5.72	4.42	3.07	2.34	2.31	2.52	2.50	2.13	2.05	2.93	3.97
Enterprise Value to Revenue (EV/Rev)	5.95	5.26	3.79	3.10	3.14	8.07	4.57	3.50	2.85	4.52	5.38
Enterprise Value to EBITDA (EV/EBITDA)	16.91	18.63	14.75	11.36	8.81	0.00	16.84	19.12	9.48	14.31	14.84
Enterprise Value to EBIT (EV/EBIT)	25.07	33.04	46.61	25.95	16.05	0.00	110.60	0.00	21.20	36.32	26.19
Enterprise Value to NOPAT (EV/NOPAT)	32.92	47.07	104.07	32.83	20.65	0.00	0.00	0.00	29.57	41.87	36.41
Enterprise Value to Operating Cash Flow (EV/OCF)	26.41	25.49	16.89	10.54	13.73	0.00	191.86	60.71	18.23	22.49	17.36
Enterprise Value to Free Cash Flow (EV/FCFF)	641.10	0.00	0.00	104.85	67.35	96.61	0.00	0.00	118.11	102.04	44.75
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.04	0.04	0.04	0.06	0.03	0.66	0.53	0.80	0.73	0.70	0.65
Long-Term Debt to Equity	0.04	0.04	0.04	0.06	0.03	0.66	0.53	0.80	0.73	0.70	0.65
Financial Leverage	-0.35	-0.36	-0.25	-0.20	-0.17	-0.12	0.01	0.26	0.50	0.47	0.36
Leverage Ratio	1.41	1.37	1.40	1.45	1.42	1.70	2.10	2.24	2.42	2.27	2.14
Compound Leverage Factor	1.38	1.32	1.36	1.41	1.38	1.81	2.19	4.53	2.22	1.95	1.61
Debt to Total Capital	4.14%	4.18%	4.03%	5.93%	2.76%	39.68%	34.44%	44.37%	42.17%	41.31%	39.44%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	4.14%	4.18%	4.03%	5.93%	2.76%	39.68%	34.44%	44.37%	42.17%	41.31%	39.44%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	7.54%	9.87%	12.06%	13.69%	14.43%	9.18%	11.32%	11.20%	12.12%	12.22%	12.72%
Common Equity to Total Capital	88.32%	85.95%	83.91%	80.39%	82.82%	51.14%	54.24%	44.43%	45.70%	46.47%	47.84%
Debt to EBITDA	0.22	0.26	0.26	0.37	0.13	-4.48	3.27	4.78	2.24	2.39	1.87
Net Debt to EBITDA	-2.19	-1.67	-1.36	-1.03	-0.76	0.37	0.51	2.99	1.56	1.49	0.86
Long-Term Debt to EBITDA	0.22	0.26	0.26	0.37	0.13	-4.48	3.27	4.78	2.24	2.39	1.87
Debt to NOPAT	0.43	0.65	1.83	1.07	0.30	-3.58	-23.62	-77.73	6.98	7.00	4.60
Net Debt to NOPAT	-4.27	-4.21	-9.63	-2.97	-1.78	0.30	-3.69	-48.64	4.87	4.35	2.10
Long-Term Debt to NOPAT	0.43	0.65	1.83	1.07	0.30	-3.58	-23.62	-77.73	6.98	7.00	4.60
Altman Z-Score	7.02	6.42	4.14	3.26	4.07	1.06	1.83	1.24	1.39	2.04	3.13
Noncontrolling Interest Sharing Ratio	8.80%	9.04%	11.41%	13.55%	14.70%	15.00%	16.20%	18.51%	20.56%	20.89%	20.92%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.58	2.32	1.92	2.23	2.93	2.67	3.75	2.85	1.87	1.47	1.75
Quick Ratio	2.38	2.08	1.76	1.81	2.53	2.43	3.45	2.55	1.55	1.20	1.48
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	3.47	-18	-7.28	11	18	11	-36	-32	9.05	16	49
Operating Cash Flow to CapEx	194.66%	509.70%	353.58%	822.65%	1,217.84%	-3,301.43%	168.94%	205.61%	903.02%	840.50%	1,555.87%
Free Cash Flow to Firm to Interest Expense	2.09	-8.04	-3.75	3.79	5.22	1.63	-5.05	-4.98	1.25	1.84	2.16
Operating Cash Flow to Interest Expense	50.70	34.86	43.96	37.71	25.60	-3.28	0.86	2.69	8.11	8.36	5.56
Operating Cash Flow Less CapEx to Interest Expense	24.65	28.02	31.53	33.13	23.50	-3.38	0.35	1.38	7.21	7.37	5.20
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.48	0.42	0.44	0.43	0.45	0.15	0.27	0.35	0.46	0.43	0.48
Accounts Receivable Turnover	1.88	1.74	1.59	2.12	4.10	1.76	3.06	2.44	2.75	2.89	3.80
Inventory Turnover	5.54	4.32	5.36	4.50	4.20	3.26	3.50	4.94	5.09	5.03	5.02
Fixed Asset Turnover	1.86	1.63	1.46	1.34	1.35	0.47	0.95	1.17	1.51	1.46	1.70
Accounts Payable Turnover	6.23	8.04	8.84	6.03	7.01	6.53	6.34	7.02	6.22	7.02	8.35
Days Sales Outstanding (DSO)	193.81	209.76	229.35	172.24	88.94	207.56	119.11	149.37	132.63	126.39	95.98
Days Inventory Outstanding (DIO)	65.92	84.51	68.05	81.08	86.87	111.89	104.16	73.86	71.77	72.57	72.71
Days Payable Outstanding (DPO)	58.58	45.40	41.28	60.57	52.07	55.90	57.60	52.03	58.70	52.03	43.71
Cash Conversion Cycle (CCC)	201.15	248.87	256.12	192.74	123.75	263.55	165.66	171.20	145.70	146.94	124.98
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	389	449	470	494	536	439	466	494	521	544	555
Invested Capital Turnover	1.05	0.90	0.83	0.78	0.77	0.28	0.56	0.63	0.74	0.66	0.75
Increase / (Decrease) in Invested Capital	64	60	21	24	42	-97	26	29	27	22	11
Enterprise Value (EV)	2,224	1,985	1,442	1,160	1,241	1,106	1,164	1,052	1,069	1,593	2,206
Market Capitalization	2,459	2,098	1,499	1,177	1,252	1,061	1,054	821	820	1,349	1,988
Book Value per Share	$9.02	$8.41	$8.15	$8.18	$8.94	$6.69	$6.03	$4.71	$5.00	$5.68	$6.28
Tangible Book Value per Share	$8.03	$7.37	$7.07	$7.02	$7.80	$5.58	$4.98	$3.18	$3.39	$4.02	$4.83
Total Capital	706	654	629	637	661	770	656	593	598	644	706
Total Debt	29	27	25	38	18	306	226	263	252	266	279
Total Long-Term Debt	29	27	25	38	18	306	226	263	252	266	279
Net Debt	-288	-177	-133	-105	-107	-25	35	165	176	166	127
Capital Expenditures (CapEx)	43	15	24	13	7.42	0.70	3.59	8.42	6.49	8.43	8.17
Debt-free, Cash-free Net Working Capital (DFCFNWC)	36	64	61	18	148	30	162	167	43	-20	-20
Debt-free Net Working Capital (DFNWC)	354	269	219	160	257	347	352	264	119	81	131
Net Working Capital (NWC)	354	269	219	160	257	347	352	264	119	81	131
Net Nonoperating Expense (NNE)	2.94	2.86	1.33	1.72	1.51	72	0.00	16	3.07	5.35	15
Net Nonoperating Obligations (NNO)	-288	-177	-133	-105	-107	-25	35	165	176	166	127
Total Depreciation and Amortization (D&A)	43	46	67	57	63	54	59	60	62	67	64
Debt-free, Cash-free Net Working Capital to Revenue	9.70%	16.90%	15.95%	4.91%	37.30%	21.85%	63.55%	55.48%	11.42%	-5.61%	-4.80%
Debt-free Net Working Capital to Revenue	94.63%	71.16%	57.64%	42.73%	64.97%	253.51%	137.98%	87.86%	31.74%	22.95%	32.05%
Net Working Capital to Revenue	94.63%	71.16%	57.64%	42.73%	64.97%	253.51%	137.98%	87.86%	31.74%	22.95%	32.05%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.79	$0.43	$0.04	$0.36	$0.76	($2.43)	($0.38)	($0.40)	$0.47	$0.49	$0.65
Adjusted Weighted Average Basic Shares Outstanding	69.69M	66.31M	64.90M	61.48M	61.36M	58.95M	58.58M	56.67M	54.31M	52.65M	53.64M
Adjusted Diluted Earnings per Share	$0.78	$0.42	$0.04	$0.36	$0.76	($2.43)	($0.38)	($0.40)	$0.46	$0.48	$0.63
Adjusted Weighted Average Diluted Shares Outstanding	69.69M	66.31M	64.90M	61.48M	61.36M	58.95M	58.58M	56.67M	55.15M	53.86M	55.54M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.76	($2.43)	($0.38)	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	69.69M	66.31M	64.90M	61.48M	61.36M	58.95M	58.58M	53.97M	52.95M	53.02M	53.99M
Normalized Net Operating Profit after Tax (NOPAT)	68	42	34	52	61	-82	6.45	-0.25	38	41	67
Normalized NOPAT Margin	18.24%	11.26%	8.98%	13.88%	15.35%	-59.56%	2.53%	-0.08%	10.23%	11.73%	16.43%
Pre Tax Income Margin	23.30%	15.33%	7.88%	11.65%	19.04%	-94.25%	4.31%	-3.25%	12.30%	10.70%	15.43%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	53.43	26.90	15.92	15.32	21.89	-17.38	1.48	-0.75	6.97	5.18	3.68
NOPAT to Interest Expense	40.67	18.88	7.13	12.11	17.02	-12.16	-1.35	-0.53	5.00	4.49	2.65
EBIT Less CapEx to Interest Expense	27.38	20.06	3.49	10.74	19.79	-17.48	0.98	-2.06	6.07	4.18	3.33
NOPAT Less CapEx to Interest Expense	14.63	12.04	-5.30	7.53	14.92	-12.26	-1.86	-1.84	4.10	3.50	2.29
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	14.72%	0.00%	0.00%	20.64%	7.48%	-2.68%	-51.05%	-13.60%	4.35%	0.00%	0.00%
Augmented Payout Ratio	92.91%	5.08%	368.59%	233.41%	44.74%	-26.91%	-301.28%	-432.01%	85.51%	54.95%	3.19%

This table displays calculated financial ratios and metrics derived from IMAX's official financial filings.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
DEI Shares Outstanding	-	-	-	-	-	-	-	-	-	-	54,855,176.00
DEI Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-	-	54,855,176.00
DEI Earnings Per Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-	-	0.08
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	51.11%	-12.27%	-9.00%	-9.20%	-11.98%	7.74%	9.53%	3.06%	16.62%	35.11%	-6.10%
EBITDA Growth	249.11%	-24.59%	8.96%	-22.88%	-16.74%	58.57%	16.12%	38.42%	29.75%	52.71%	-20.02%
EBIT Growth	603.24%	-63.66%	4.90%	-80.46%	-11.90%	247.28%	39.33%	399.51%	49.63%	153.41%	-40.69%
NOPAT Growth	617.02%	23.06%	5.93%	29.45%	9.59%	26.40%	42.92%	-3.50%	40.47%	17.46%	-19.49%
Net Income Growth	293.62%	-18.87%	5.80%	-47.23%	2.16%	107.37%	50.37%	141.18%	47.40%	-63.22%	-25.51%
EPS Growth	237.50%	25.00%	50.00%	-53.33%	18.18%	80.00%	-33.33%	185.71%	42.31%	-77.78%	75.00%
Operating Cash Flow Growth	397.97%	-76.21%	-151.69%	655.62%	22.71%	186.62%	163.38%	-33.70%	91.35%	155.76%	-42.04%
Free Cash Flow Firm Growth	73.82%	11.61%	-390.73%	-51.15%	-279.84%	30.13%	84.18%	-13.25%	154.66%	85.74%	109.32%
Invested Capital Growth	4.44%	5.48%	11.73%	7.43%	7.88%	4.30%	3.09%	7.40%	2.09%	2.08%	1.12%
Revenue Q/Q Growth	6.04%	-17.21%	-8.02%	12.43%	2.80%	1.33%	-6.48%	5.79%	16.33%	17.40%	-35.00%
EBITDA Q/Q Growth	45.90%	-59.87%	64.61%	-19.99%	57.51%	-23.56%	20.54%	-4.16%	46.94%	-10.04%	-36.87%
EBIT Q/Q Growth	55.73%	-87.57%	336.66%	-76.88%	602.03%	-51.00%	75.19%	-13.91%	102.46%	-17.01%	-58.99%
NOPAT Q/Q Growth	46.63%	-59.53%	-0.40%	119.02%	24.13%	-53.32%	12.62%	47.88%	80.70%	-60.97%	-22.81%
Net Income Q/Q Growth	56.24%	-77.95%	63.70%	-6.40%	202.44%	-55.25%	18.70%	50.12%	84.85%	-88.84%	140.44%
EPS Q/Q Growth	46.67%	-77.27%	20.00%	16.67%	271.43%	-65.38%	-55.56%	400.00%	85.00%	-94.59%	250.00%
Operating Cash Flow Q/Q Growth	520.08%	-86.06%	-373.72%	419.46%	0.70%	-67.45%	-39.48%	234.20%	190.63%	-56.49%	-86.28%
Free Cash Flow Firm Q/Q Growth	61.58%	-251.12%	-146.78%	54.60%	3.45%	35.41%	44.13%	-225.07%	146.60%	-116.84%	136.54%
Invested Capital Q/Q Growth	0.57%	4.26%	5.44%	-2.83%	0.99%	0.80%	4.22%	1.24%	-4.01%	0.79%	3.24%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	60.36%	51.05%	59.26%	49.38%	55.79%	52.19%	61.36%	58.46%	63.07%	57.62%	56.29%
EBITDA Margin	40.24%	19.50%	34.90%	24.84%	38.06%	28.71%	37.00%	33.52%	42.34%	32.45%	31.52%
Operating Margin	21.21%	3.18%	15.25%	3.23%	21.23%	10.26%	19.31%	15.65%	27.23%	19.25%	12.23%
EBIT Margin	21.21%	3.18%	15.12%	3.11%	21.23%	10.26%	19.23%	15.65%	27.23%	19.25%	12.15%
Profit (Net Income) Margin	14.46%	3.85%	6.85%	5.70%	16.78%	7.41%	9.40%	13.34%	21.21%	2.02%	7.46%
Tax Burden Percent	69.62%	226.63%	51.23%	471.47%	86.59%	82.48%	52.80%	91.08%	81.29%	38.23%	71.49%
Interest Burden Percent	97.92%	53.34%	88.45%	38.92%	91.28%	87.51%	92.62%	93.64%	95.79%	27.40%	85.92%
Effective Tax Rate	30.38%	-126.63%	48.77%	-371.47%	13.41%	17.52%	47.20%	8.92%	18.71%	61.77%	28.51%
Return on Invested Capital (ROIC)	11.67%	5.33%	5.50%	10.56%	12.22%	5.60%	6.57%	9.32%	15.34%	5.49%	6.21%
ROIC Less NNEP Spread (ROIC-NNEP)	11.44%	3.62%	5.10%	5.74%	11.29%	5.02%	6.23%	8.86%	14.64%	0.93%	5.57%
Return on Net Nonoperating Assets (RNNOA)	4.67%	1.83%	2.86%	2.96%	4.89%	2.37%	3.46%	4.27%	5.20%	0.34%	2.25%
Return on Equity (ROE)	16.34%	7.15%	8.37%	13.52%	17.11%	7.97%	10.03%	13.59%	20.54%	5.83%	8.46%
Cash Return on Invested Capital (CROIC)	3.17%	1.78%	-4.07%	-0.76%	-0.83%	2.93%	4.19%	1.26%	7.73%	8.97%	9.36%
Operating Return on Assets (OROA)	9.94%	1.46%	6.74%	1.35%	8.64%	4.40%	8.27%	6.69%	11.84%	9.16%	5.65%
Return on Assets (ROA)	6.77%	1.76%	3.06%	2.48%	6.83%	3.17%	4.05%	5.70%	9.22%	0.96%	3.47%
Return on Common Equity (ROCE)	13.16%	5.68%	6.56%	10.69%	13.60%	6.30%	7.80%	10.68%	16.31%	4.61%	6.61%
Return on Equity Simple (ROE_SIMPLE)	11.79%	0.00%	12.89%	10.79%	10.07%	0.00%	11.83%	13.29%	0.00%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	15	6.21	6.18	14	17	7.85	8.84	13	24	9.22	7.11
NOPAT Margin	14.76%	7.22%	7.81%	15.22%	18.38%	8.47%	10.20%	14.25%	22.14%	7.36%	8.74%
Net Nonoperating Expense Percent (NNEP)	0.22%	1.70%	0.41%	4.82%	0.93%	0.57%	0.34%	0.46%	0.70%	4.57%	0.64%
Return On Investment Capital (ROIC_SIMPLE)	-	1.04%	-	-	-	1.22%	1.33%	1.91%	3.41%	1.31%	0.99%
Cost of Revenue to Revenue	39.64%	48.95%	40.78%	50.62%	44.21%	47.77%	38.64%	41.54%	36.93%	42.38%	43.71%
SG&A Expenses to Revenue	34.92%	40.77%	39.50%	42.23%	34.41%	34.98%	38.61%	38.50%	32.08%	28.33%	39.92%
R&D to Revenue	2.67%	3.16%	2.76%	2.28%	-0.29%	1.24%	1.52%	1.68%	1.41%	1.16%	2.22%
Operating Expenses to Revenue	39.16%	47.86%	43.97%	46.15%	34.56%	41.96%	42.19%	42.82%	35.84%	38.27%	44.07%
Earnings before Interest and Taxes (EBIT)	22	2.74	12	2.77	19	9.51	17	14	29	24	9.88
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	42	17	28	22	35	27	32	31	45	41	26
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	3.68	3.00	3.41	3.30	3.73	4.50	4.67	4.69	5.04	5.88	6.12
Price to Tangible Book Value (P/TBV)	5.28	4.43	5.16	4.92	5.34	6.38	6.60	6.44	6.69	7.66	7.93
Price to Revenue (P/Rev)	2.73	2.19	2.41	2.47	3.13	3.83	3.88	4.15	4.66	4.85	5.07
Price to Earnings (P/E)	41.53	32.37	33.76	41.26	46.38	51.75	55.64	45.83	44.54	57.01	55.81
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	2.41%	3.09%	2.96%	2.42%	2.16%	1.93%	1.80%	2.18%	2.25%	1.75%	1.79%
Enterprise Value to Invested Capital (EV/IC)	2.54	2.05	2.14	2.15	2.47	2.93	2.94	3.06	3.56	3.97	4.00
Enterprise Value to Revenue (EV/Rev)	3.28	2.85	3.20	3.21	3.85	4.52	4.63	4.84	5.20	5.38	5.66
Enterprise Value to EBITDA (EV/EBITDA)	10.74	9.48	10.21	10.59	13.11	14.31	14.38	14.13	14.58	14.84	16.10
Enterprise Value to EBIT (EV/EBIT)	22.98	21.20	22.99	28.95	35.87	36.32	34.30	29.27	28.18	26.19	29.57
Enterprise Value to NOPAT (EV/NOPAT)	34.47	29.57	32.17	34.84	37.95	41.87	41.19	37.73	36.74	36.41	38.35
Enterprise Value to Operating Cash Flow (EV/OCF)	17.75	18.23	44.42	20.23	21.00	22.49	18.75	22.82	17.98	17.36	18.45
Enterprise Value to Free Cash Flow (EV/FCFF)	81.77	118.11	0.00	0.00	0.00	102.04	71.07	251.55	46.56	44.75	42.92
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.71	0.73	0.89	0.82	0.75	0.70	0.73	0.69	0.59	0.65	0.68
Long-Term Debt to Equity	0.71	0.73	0.89	0.82	0.75	0.70	0.73	0.69	0.59	0.65	0.68
Financial Leverage	0.41	0.50	0.56	0.52	0.43	0.47	0.56	0.48	0.36	0.36	0.40
Leverage Ratio	2.37	2.42	2.47	2.41	2.34	2.27	2.33	2.27	2.16	2.14	2.14
Compound Leverage Factor	2.33	1.29	2.18	0.94	2.14	1.99	2.16	2.12	2.07	0.59	1.84
Debt to Total Capital	41.39%	42.17%	47.15%	45.20%	42.90%	41.31%	42.12%	40.70%	37.07%	39.44%	40.44%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	41.39%	42.17%	47.15%	45.20%	42.90%	41.31%	42.12%	40.70%	37.07%	39.44%	40.44%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	11.54%	12.12%	11.82%	12.11%	12.16%	12.22%	12.77%	12.39%	12.56%	12.72%	12.91%
Common Equity to Total Capital	47.07%	45.70%	41.02%	42.69%	44.94%	46.47%	45.11%	46.91%	50.37%	47.84%	46.65%
Debt to EBITDA	2.14	2.24	2.59	2.61	2.72	2.39	2.42	2.24	1.91	1.87	2.04
Net Debt to EBITDA	1.21	1.56	1.88	1.76	1.69	1.49	1.58	1.36	0.85	0.86	1.02
Long-Term Debt to EBITDA	2.14	2.24	2.59	2.61	2.72	2.39	2.42	2.24	1.91	1.87	2.04
Debt to NOPAT	6.86	6.98	8.15	8.57	7.88	7.00	6.92	5.97	4.82	4.60	4.87
Net Debt to NOPAT	3.88	4.87	5.93	5.80	4.90	4.35	4.52	3.63	2.14	2.10	2.43
Long-Term Debt to NOPAT	6.86	6.98	8.15	8.57	7.88	7.00	6.92	5.97	4.82	4.60	4.87
Altman Z-Score	1.66	1.19	1.47	1.15	1.48	1.91	2.05	2.23	2.66	2.91	2.97
Noncontrolling Interest Sharing Ratio	19.41%	20.56%	21.64%	20.96%	20.51%	20.89%	22.21%	21.45%	20.57%	20.92%	21.86%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.88	1.87	3.31	1.39	1.41	1.47	2.25	2.44	1.68	1.75	1.90
Quick Ratio	1.63	1.55	2.90	1.13	1.15	1.20	1.86	2.02	1.37	1.48	1.58
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-5.95	-21	-52	-23	-23	-15	-8.15	-26	12	-2.08	0.76
Operating Cash Flow to CapEx	1,876.83%	101.44%	-993.48%	2,209.21%	3,133.39%	249.02%	422.55%	983.91%	2,460.39%	2,072.97%	188.98%
Free Cash Flow to Firm to Interest Expense	-3.81	-10.27	-26.49	-10.25	-9.62	-7.70	-4.53	-12.86	6.80	-0.12	0.40
Operating Cash Flow to Interest Expense	18.43	1.97	-5.64	15.35	15.02	6.06	3.86	11.28	37.20	1.71	2.13
Operating Cash Flow Less CapEx to Interest Expense	17.45	0.03	-6.21	14.66	14.54	3.63	2.95	10.13	35.69	1.63	1.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.47	0.46	0.45	0.44	0.41	0.43	0.43	0.43	0.43	0.48	0.47
Accounts Receivable Turnover	2.96	2.75	2.78	2.90	2.76	2.89	2.74	2.92	3.39	3.80	3.51
Inventory Turnover	4.11	5.09	4.29	4.34	3.91	5.03	4.81	4.20	3.93	5.02	4.92
Fixed Asset Turnover	1.58	1.51	1.50	1.50	1.43	1.46	1.48	1.51	1.54	1.70	1.67
Accounts Payable Turnover	5.57	6.22	7.09	7.37	5.09	7.02	7.46	6.04	6.40	8.35	7.86
Days Sales Outstanding (DSO)	123.43	132.63	131.26	126.06	132.12	126.39	133.38	125.10	107.57	95.98	104.06
Days Inventory Outstanding (DIO)	88.81	71.77	85.16	84.19	93.47	72.57	75.88	86.98	92.91	72.71	74.22
Days Payable Outstanding (DPO)	65.52	58.70	51.48	49.50	71.77	52.03	48.96	60.45	57.01	43.71	46.43
Cash Conversion Cycle (CCC)	146.72	145.70	164.94	160.75	153.81	146.94	160.30	151.62	143.47	124.98	131.85
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	500	521	550	534	540	544	567	574	551	555	573
Invested Capital Turnover	0.79	0.74	0.70	0.69	0.66	0.66	0.64	0.65	0.69	0.75	0.71
Increase / (Decrease) in Invested Capital	21	27	58	37	39	22	17	40	11	11	6.35
Enterprise Value (EV)	1,268	1,069	1,174	1,150	1,331	1,593	1,664	1,756	1,963	2,206	2,290
Market Capitalization	1,055	820	883	882	1,080	1,349	1,397	1,503	1,761	1,988	2,052
Book Value per Share	$5.26	$5.00	$4.93	$5.08	$5.49	$5.68	$5.65	$5.96	$6.50	$6.28	$6.21
Tangible Book Value per Share	$3.66	$3.39	$3.26	$3.41	$3.84	$4.02	$3.99	$4.34	$4.89	$4.83	$4.79
Total Capital	610	598	631	626	644	644	664	683	694	706	719
Total Debt	252	252	297	283	276	266	280	278	257	279	291
Total Long-Term Debt	252	252	297	283	276	266	280	278	257	279	291
Net Debt	143	176	216	191	172	166	183	169	114	127	145
Capital Expenditures (CapEx)	1.53	3.95	1.10	1.59	1.13	4.61	1.65	2.36	2.74	1.42	2.13
Debt-free, Cash-free Net Working Capital (DFCFNWC)	92	43	195	-18	-26	-20	50	60	-18	-20	-0.44
Debt-free Net Working Capital (DFNWC)	201	119	276	74	79	81	147	169	125	131	146
Net Working Capital (NWC)	201	119	276	74	79	81	147	169	125	131	146
Net Nonoperating Expense (NNE)	0.32	2.90	0.76	8.47	1.47	0.98	0.69	0.83	1.00	6.69	1.04
Net Nonoperating Obligations (NNO)	143	176	216	191	172	166	183	169	114	127	145
Total Depreciation and Amortization (D&A)	20	14	16	19	15	17	15	16	16	17	16
Debt-free, Cash-free Net Working Capital to Revenue	23.74%	11.42%	53.21%	-5.01%	-7.48%	-5.61%	13.99%	16.49%	-4.82%	-4.80%	-0.11%
Debt-free Net Working Capital to Revenue	52.07%	31.74%	75.28%	20.56%	22.76%	22.95%	40.97%	46.63%	33.07%	32.05%	35.95%
Net Working Capital to Revenue	52.07%	31.74%	75.28%	20.56%	22.76%	22.95%	40.97%	46.63%	33.07%	32.05%	35.95%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.22	$0.05	$0.06	$0.07	$0.26	$0.10	$0.04	$0.21	$0.38	$0.02	$0.08
Adjusted Weighted Average Basic Shares Outstanding	54.62M	54.31M	52.50M	52.63M	52.68M	52.65M	53.15M	53.75M	53.79M	53.64M	54.13M
Adjusted Diluted Earnings per Share	$0.22	$0.05	$0.06	$0.07	$0.26	$0.09	$0.04	$0.20	$0.37	$0.02	$0.07
Adjusted Weighted Average Diluted Shares Outstanding	55.54M	55.15M	53.41M	53.43M	54.09M	53.86M	54.97M	55.16M	55.57M	55.54M	56.39M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	54.61M	52.95M	52.62M	52.68M	52.68M	53.02M	53.74M	53.78M	53.80M	53.99M	54.86M
Normalized Net Operating Profit after Tax (NOPAT)	15	3.03	6.18	2.01	17	11	8.87	14	24	18	7.11
Normalized NOPAT Margin	14.76%	3.53%	7.81%	2.26%	18.38%	11.80%	10.23%	15.03%	22.14%	14.39%	8.74%
Pre Tax Income Margin	20.77%	1.70%	13.37%	1.21%	19.38%	8.98%	17.81%	14.65%	26.09%	5.27%	10.44%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	14.12	1.35	6.15	1.21	8.26	5.02	9.25	6.96	16.00	1.40	5.21
NOPAT to Interest Expense	9.83	3.05	3.18	5.93	7.16	4.14	4.91	6.34	13.01	0.54	3.75
EBIT Less CapEx to Interest Expense	13.14	-0.60	5.58	0.52	7.78	2.59	8.34	5.82	14.49	1.32	4.09
NOPAT Less CapEx to Interest Expense	8.85	1.11	2.61	5.24	6.68	1.71	3.99	5.20	11.50	0.45	2.63
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	4.26%	4.35%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	95.30%	85.51%	123.00%	142.00%	139.56%	54.95%	0.32%	3.11%	2.65%	3.19%	0.00%

Financials Breakdown Chart

Key Financial Trends

IMAX (NYSE: IMAX) has shown improving top‑line traction and better gross margins in 2025, with profitability returning to a positive footing in parts of the year. Cash flow remains mixed across quarters, and the company continues to manage debt levels, which has implications for liquidity and flexibility going forward.

Q4 2025 Revenue: Operating Revenue rose to $125.2 million, up from prior-year quarters, signaling ongoing revenue recovery into the year end.
Gross margin improvement: Q3 2025 gross margin was roughly 63% (gross profit about $67.27 million on $106.65 million revenue), with Q4 2025 also showing a solid margin (about 57.6%). This marks an improvement versus earlier periods in 2024 and 2023.
Bottom-line improvement: Net income from continuing operations turned positive in Q3 2025 (about $22.6 million) and remained positive in Q4 2025 (about $2.5 million), indicating improving profitability.
Operating cash flow strength: 2025 quarters featured sturdy operating cash flow, including about $67.5 million in net cash from continuing operating activities in Q3 2025 and about $29.4 million in Q4 2025, supporting liquidity generation.

Leverage trajectory: Long-term debt declined through 2025 (roughly $278.0 million at Q2 2025 to about $257.2 million at Q3 2025), suggesting deleveraging progress.
Cost discipline: Selling, General & Administrative (SG&A) and R&D expenses remained relatively stable in 2025 (SG&A generally in the low‑to‑mid $30s millions with modest R&D spend), implying maintained cost control as revenue grew.
Moderate investing activity: Net cash used in investing activities remained negative but modest in 2025 (for example, around $7 million negative in Q4 2025), consistent with ongoing capex without aggressive expansion.

Quarter-to-quarter earnings volatility: While Q3 2025 showed a strong positive bottom line, Q4 2025 dip to about $2.5 million in net income from continuing operations highlights ongoing quarterly variability.
Non-operating items can be material: Total Other Income / (Expense), net was negative in several quarters (e.g., about -$17.5 million in Q4 2025 and smaller negatives in other periods), which can impact reported profitability.
Financing activity remains a cash outflow in many quarters: Net cash from financing activities was often negative in 2025, indicating reliance on debt issuance and repayments rather than generating net cash from financing, which can affect liquidity if not offset by operating cash flow.

05/21/26 06:14 PM ETAI Generated. May Contain Errors.

IMAX Financials - Frequently Asked Questions

According to the most recent income statement we have on file, IMAX's fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

IMAX's net income appears to be on a downward trend, with a most recent value of $45.53 million in 2025, falling from $64.62 million in 2015. The previous period was $32.70 million in 2024. Check out IMAX's forecast to explore projected trends and price targets.

IMAX's total operating income in 2025 was $84.23 million, based on the following breakdown:

Total Gross Profit: $246.19 million
Total Operating Expenses: $161.96 million

Over the last 10 years, IMAX's total revenue changed from $373.81 million in 2015 to $410.21 million in 2025, a change of 9.7%.

IMAX's total liabilities were at $466.30 million at the end of 2025, a 3.1% increase from 2024, and a 84.0% increase since 2015.

In the past 10 years, IMAX's cash and equivalents has ranged from $76.20 million in 2023 to $317.45 million in 2015, and is currently $151.17 million as of their latest financial filing in 2025.

Over the last 10 years, IMAX's book value per share changed from 9.02 in 2015 to 6.28 in 2025, a change of -30.3%.

Related Companies

Financial statements for NYSE:IMAX last updated on 5/3/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

IMAX (IMAX) Financials

Financials Breakdown Chart

Key Financial Trends

IMAX Financials - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

IMAX (IMAX) Financials

Annual Income Statements for IMAX

Quarterly Income Statements for IMAX

Annual Cash Flow Statements for IMAX

Quarterly Cash Flow Statements for IMAX

Annual Balance Sheets for IMAX

Quarterly Balance Sheets for IMAX

Annual Metrics And Ratios for IMAX

Quarterly Metrics And Ratios for IMAX

Financials Breakdown Chart

Key Financial Trends

IMAX Financials - Frequently Asked Questions

When does IMAX's financial year end?

How has IMAX's net income changed over the last 10 years?

What is IMAX's operating income?

How has IMAX's revenue changed over the last 10 years?

How much debt does IMAX have?

How much cash does IMAX have?

How has IMAX's book value per share changed over the last 10 years?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools